Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

BACKGROUND: A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied. METHODS: We carried out a population-based case–control study in the Lombardy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancia, Giuseppe, Rea, Federico, Ludergnani, Monica, Apolone, Giovanni, Corrao, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206933/
https://www.ncbi.nlm.nih.gov/pubmed/32356627
http://dx.doi.org/10.1056/NEJMoa2006923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206933/
https://www.ncbi.nlm.nih.gov/pubmed/32356627
http://dx.doi.org/10.1056/NEJMoa2006923

Ejemplares similares